Document is current
Any future updates will be listed below
-
Authors
Mallah, Khalil
Couch, Christine
Alshareef, Mohammed
Borucki, Davis
Yang, Xiaofeng
Alawieh, Ali
Tomlinson, Stephen https://orcid.org/0000-0002-6281-2122
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (1BX004256)
U.S. Department of Veterans Affairs (1RX001141)
U.S. Department of Veterans Affairs (IK6BX005235)
National Institutes of Health (T32AI132164)
National Center for Advancing Translational Sciences (TL1 TR001451)
National Center for Advancing Translational Sciences (UL1 TR001450)
Neurosurgery Research and Education Foundation
- License Information
-
More Information
Article History
Received: 11 March 2021
Accepted: 10 April 2021
First Online: 20 April 2021
Declarations
:
: All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) at the Medical University of South Carolina and Ralph H. Johnson VA Medical Center.
: ST is an inventor on a licensed patent for CR2-targeted complement inhibition.
